ArticleObesity surgery2026
Comprehensive Long-Term Outcomes and Durability of Sleeve Gastrectomy with Up to 14 Years of Follow-up.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond initial weight loss: procedure-specific predictors of weight recurrence after metabolic and bariatric surgery.Surgical endoscopy · 2026Article
- Beyond Initial Resolution: Predictors of Recurrence of Obesity-related Medical Conditions after Metabolic and Bariatric Surgery.Obesity surgery · 2026Article
- Management of obesity in advanced chronic liver disease.JHEP reports : innovation in hepatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSleeve gastrectomy (SG) is the most commonly performed metabolic and bariatric surgery, yet literature on long-term outcomes, including weight loss durability and safety, remains limited.
methodsThis retrospective cohort study examined patients from 3 bariatric centers of excellence undergoing SG from 2010 to 2014 to allow for 10 years of follow-up period. Baseline characteristics, annual weight and body mass index (BMI), obesity-related medical conditions resolution and recurrence, and complications were documented. Statistical methods included paired t-test, Kaplan-Meier curve, and multivariate regression.
resultsA total of 830 patients (73.3% female, mean age 45.6 ± 11.6, mean preoperative BMI 45.6 ± 7.8 kg/m
conclusionOverall, SG demonstrates relatively favorable long-term outcomes, but the notable rates of recurrent weight gain raise concern regarding its durability. KEY POINTS: Sleeve gastrectomy resulted in significant weight loss, with a peak at 24 months. 57.5-63.9% of the cohort had recurrent weight gain; 10.1% required revision surgery. SG counseling must include long-term outcomes and potential need for revision.
Indexed as
Identifiers
41410827What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.